Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873573 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
A NA study of Dysphagia, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01873573: Completed NA study of Dysphagia, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01873573 is a NA study of Dysphagia that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 10 participants, below the 172-participant average among 35 other Dysphagia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01873573, a NA study of Dysphagia, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their esophagus and decrease the need for repeat dilations.
Primary Outcome
The main outcome measured will be number of visits to receive Esophageal Dilation during the 12-month follow-up period. Successful dilation of the stricture for the procedure will be defined as creation of a mucosal tear confirmed by endoscopic visualization after the last dilation is performed.
Conditions Studied
Interventions
- PROCEDURE Dilation
- OTHER Triamcinolone Injection
- PROCEDURE Esophagogastroduodenoscopy (EGD)
Study Locations (1)
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-07-18 |
| Est. Completion | 2017-10-16 |
| Phase | NA |
What the finished NCT01873573 record still lists
NCT01873573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 172-participant average among 35 other Dysphagia trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which Dilation is the first listed.
NCT01873573 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01873573 about?
NCT01873573 is a clinical study titled "Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection". The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the opening of their esophagus and decrease the need for repeat dilations.
What is the current status of trial NCT01873573?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-07-18. Estimated completion is 2017-10-16.
What conditions does trial NCT01873573 study?
This clinical trial studies the following conditions: Dysphagia.
What interventions are being tested in trial NCT01873573?
The interventions under investigation include: Dilation (PROCEDURE), Triamcinolone Injection (OTHER), Esophagogastroduodenoscopy (EGD) (PROCEDURE).
Who is sponsoring clinical trial NCT01873573?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01873573 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01873573's enrollment target sits among peer trials
10 35th of 35 higher than 1 of 35 other Dysphagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI